Jane Street
XERS icon

Jane Street’s Xeris Biopharma Holdings XERS Stock Holding History

Jane Street’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21M Buy
725,616
+547,794
+308% +$3.63M ﹤0.01% 3758
2025
Q4 		$1.4M Sell
177,822
-735,936
-81% -$5.79M ﹤0.01% 5459
2025
Q3 		$7.44M Buy
913,758
+882,593
+2,832% +$5.86M ﹤0.01% 2827
2025
Q2 		$146K Sell
31,165
-789,057
-96% -$3.62M ﹤0.01% 8773
2025
Q1 		$4.5M Buy
820,222
+513,977
+168% +$2.07M ﹤0.01% 3088
2024
Q4 		$1.04M Sell
306,245
-12,515
-4% -$40.3K ﹤0.01% 5311
2024
Q3 		$908K Sell
318,760
-28,832
-8% -$74K ﹤0.01% 6079
2024
Q2 		$782K Buy
347,592
+117,634
+51% +$237K ﹤0.01% 6248
2024
Q1 		$508K Buy
229,958
+6,374
+3% +$16.5K ﹤0.01% 6631
2023
Q4 		$525K Buy
223,584
+79,980
+56% +$148K ﹤0.01% 6671
2023
Q3 		$267K Buy
143,604
+17,189
+14% +$39.4K ﹤0.01% 7238
2023
Q2 		$331K Sell
126,415
-9,407
-7% -$23.9K ﹤0.01% 6969
2023
Q1 		$221K Sell
135,822
-45,740
-25% -$57.3K ﹤0.01% 7699
2022
Q4 		$241K Buy
181,562
+63,964
+54% +$90.3K ﹤0.01% 7377
2022
Q3 		$183K Sell
117,598
-148,698
-56% -$246K ﹤0.01% 8258
2022
Q2 		$410K Sell
266,296
-196,583
-42% -$415K ﹤0.01% 7089
2022
Q1 		$1.19M Buy
462,879
+349,469
+308% +$854K ﹤0.01% 5779
2021
Q4 		$332K Buy
113,410
+97,476
+612% +$211K ﹤0.01% 7988
2021
Q3 		$39K Sell
15,934
-14,660
-48% -$42.6K ﹤0.01% 9623
2021
Q2 		$125K Sell
30,594
-20,325
-40% -$77.6K ﹤0.01% 9160
2021
Q1 		$230K Buy
50,919
+25,495
+100% +$138K ﹤0.01% 8083
2020
Q4 		$125K Buy
+25,424
New +$127K ﹤0.01% 7139

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's XERS Position: Q1 2026 in Review

Jane Street increased its Xeris Biopharma Holdings (XERS) stake by 308% in Q1 2026, buying an estimated $3.63M and bringing the position to 725,616 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3758.

Jane Street first reported a position in XERS in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.44M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Jane Street held 725,616 shares of Xeris Biopharma Holdings worth $4.21M as of Q1 2026.
  • Jane Street bought 547,794 Xeris Biopharma Holdings shares in Q1 2026, an estimated $3.63M.
  • Xeris Biopharma Holdings made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3758 holding.
  • Jane Street first reported a position in Xeris Biopharma Holdings in Q4 2020 and has held it in 22 quarters since.
  • Jane Street's Xeris Biopharma Holdings position peaked at $7.44M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.